E-LIB Suche - Ergebnisse für: Mayhew, Jill

1

Triheptanoin Did Not Show Benefit versus Placebo for the Tr..:

De Giorgis, Valentina ; Bhatia, Kailash P. ; Boespflug‐Tanguy, Odile...
Movement Disorders. 39 (2024) 8 - p. 1386-1396 , 2024

Link: https://doi.org/10.1002/..

2

Glycogen storage disease type III: a mixed-methods study to..:

Evins, Ayla ; Mayhew, Jill ; Cimms, Tricia...
Therapeutic Advances in Endocrinology and Metabolism. 15 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

3

eP167: The impact of glycogen storage disease type III on c..:

Mayhew, Jill ; Evins, Ayla ; Cimms, Tricia.
Genetics in Medicine. 24 (2022) 3 - p. S102 , 2022

Link: https://doi.org/10.1016/..

4

Open-label phase 1/2 study of vestronidase alfa for mucopol..:

Jones, Simon ; Coker, Mahmut ; López, Antonio González-Meneses...
Molecular Genetics and Metabolism Reports. 28 (2021) - p. 100774 , 2021

Link: https://doi.org/10.1016/..

5

PP531 Quality Of Life Of Patients With Long-Chain Fatty Aci..:

Kruger, Eliza ; Marsden, Deborah ; Bensimon, Arielle...
International Journal of Technology Assessment in Health Care. 36 (2020) S1 - p. 41-41 , 2020

Link: https://doi.org/10.1017/..

6

Liquid formulation of pentoxifylline is a poorly tolerated ..:

Zimmerman, Angela ; Clemens, Paula R. ; Tesi‐Rocha, Carolina...
Muscle & Nerve. 44 (2011) 2 - p. 170-173 , 2011

Link: https://doi.org/10.1002/..

7

CINRG pilot trial of coenzyme Q10 in steroid‐treated duchen..:

Spurney, Christopher F. ; Rocha, Carolina Tesi ; Henricson, Erik...
Muscle & Nerve. 44 (2011) 2 - p. 174-178 , 2011

Link: https://doi.org/10.1002/..

8

Clinical features of late‐onset Pompe disease: A prospectiv..:

Wokke, John H.J. ; Escolar, Diana M. ; Pestronk, Alan...
Muscle & Nerve. 38 (2008) 4 - p. 1236-1245 , 2008

Link: https://doi.org/10.1002/..

9

CINRG randomized controlled trial of creatine and glutamine..:

Escolar, Diana M. ; Buyse, Gunnar ; Henricson, Erik...
Annals of Neurology. 58 (2005) 1 - p. 151-155 , 2005

Link: https://doi.org/10.1002/..

10

Characterization of Strength and Function in Ambulatory Adu..:

Argov, Zohar ; Bronstein, Faye ; Esposito, Alicia...
Journal of Clinical Neuromuscular Disease. 19 (2017) 1 - p. 19-26 , 2017

Link: https://doi.org/10.1097/..

11

CINRG pilot trial of oxatomide in steroid-naïve Duchenne mu..:

Buyse, Gunnar M. ; Goemans, Nathalie ; Henricson, Erik...
European Journal of Paediatric Neurology. 11 (2007) 6 - p. 337-340 , 2007

Link: https://doi.org/10.1016/..

12

Reliable surrogate outcome measures in multicenter clinical..:

Mayhew, Jill E. ; Florence, Julaine M. ; Mayhew, Thomas P....
Muscle & Nerve. 35 (2006) 1 - p. 36-42 , 2006

Link: https://doi.org/10.1002/..

13

Triheptanoin Did Not Show Benefit versus Placebo for the Tr..:

De Giorgis, Valentina ; Bhatia, Kailash P ; Boespflug-Tanguy, Odile...
https://discovery.ucl.ac.uk/id/eprint/10192415/1/Triheptanoin%20Did%20Not%20Show%20Benefit%20versus%20Placebo%20for%20the%20Treatment%20of%20Paroxysmal.pdf. , 2024

Link: https://discovery.ucl.ac..

14

Open-label phase 1/2 study of vestronidase alfa for mucopol..:

Coker, Mahmut ; Jones, Simon ; Gonzalez-Meneses Lopez, Antonio...
Molecular Genetics And Metabolism Reports. , 2021

Link: https://hdl.handle.net/1..

15

Open-label phase 1/2 study of vestronidase alfa for mucopol..:

Jones, Simon ; Coker, Mahmut ; López, Antonio González-Meneses...
2214-4269. , 2021

Link: http://hdl.handle.net/10..